Blog

When medical device companies plan international market entry, one of the most common assumptions is that approval in one region will make approval in another easier. In practice, this is rarely true. India, the United States, and the European Union follow very different regulatory philosophies, documentation expectations, and review behaviors. Submissions that succeed in one

Software as a Medical Device (SaMD) is increasingly important in healthcare innovation, standalone software that performs medical purposes such as diagnosis, monitoring, prediction, or treatment without requiring a physical hardware medical device. In India, SaMD falls under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) as defined by the Medical Devices Rules,

Introduction A Free Sale Certificate (FSC) is often the final regulatory milestone before a medical device manufacturer or authorized agent can access international markets. Issued by the national regulatory authority (such as CDSCO in India), an FSC confirms that a medical device is legally marketed and compliant in its country of origin. However, one of

In the medical device regulatory lifecycle, approval is not the finish line it is the starting point of continuous compliance. One of the most underestimated risk areas for manufacturers and authorized representatives is manufacturing site changes. Whether it is a full relocation, adding a contract manufacturer, or even a warehouse shift, these changes can directly